Minerva Biotechnology and Biomolecular Research

Scope & Guideline

Fostering Knowledge in the Dynamic World of Biomolecular Research

Introduction

Explore the comprehensive scope of Minerva Biotechnology and Biomolecular Research through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Minerva Biotechnology and Biomolecular Research in depth and align your research initiatives with current academic trends.
LanguageMulti-Language
ISSN2724-542x
PublisherEDIZIONI MINERVA MEDICA
Support Open AccessNo
CountryItaly
TypeJournal
Convergefrom 2021 to 2024
AbbreviationMINERVA BIOTECHNOL B / Minerva Biotechnol. Biomolecular Res.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY

Aims and Scopes

Minerva Biotechnology and Biomolecular Research focuses on the intersection of biotechnology, molecular biology, and biomedical research, emphasizing innovative approaches to understanding and treating human diseases.
  1. Biotechnology Applications in Health Sciences:
    The journal explores various applications of biotechnology, particularly in health sciences, focusing on the development of novel therapeutic strategies and diagnostic tools.
  2. Molecular Mechanisms of Disease:
    Research published in the journal investigates the molecular and genetic underpinnings of diseases, aiming to elucidate pathways and mechanisms that could be targeted for treatment.
  3. Innovative Therapeutics and Drug Development:
    A core area of focus includes the discovery and development of new drugs, including the use of natural products, nanoparticles, and biopharmaceuticals in therapeutic contexts.
  4. Cancer Research and Therapeutics:
    The journal consistently emphasizes cancer research, exploring genetic, biochemical, and immunological aspects to improve treatment outcomes and patient care.
  5. In-silico and Computational Studies:
    There is a significant focus on in-silico approaches for drug discovery and biomarker identification, reflecting the growing importance of computational methods in biological research.
  6. Environmental and Plant Biotechnology:
    Research on the environmental applications of biotechnology, including the green synthesis of nanoparticles and the use of plant-derived compounds for health benefits, is also a notable area of interest.
Recent publications in Minerva Biotechnology and Biomolecular Research highlight several emerging themes that reflect current scientific priorities and innovations in biotechnology and molecular research.
  1. Precision Medicine and Genomics:
    An increasing focus on precision medicine, especially regarding genetic testing and tailored therapies, is evident, showcasing the journal's commitment to advancing personalized healthcare.
  2. Immunotherapy and Cancer Treatment:
    Emerging themes in immunotherapy, especially in the context of cancer treatment, indicate a growing interest in harnessing the immune system for therapeutic benefits.
  3. Sustainable and Green Biotechnology:
    There is a notable trend towards sustainable practices in biotechnology, including the green synthesis of nanoparticles and the use of plant-based compounds, reflecting a broader environmental consciousness.
  4. CRISPR and Gene Editing Technologies:
    The rise of CRISPR and other gene editing technologies as a research focus indicates the journal's alignment with cutting-edge advancements in molecular biology.
  5. Microbiome Research:
    Research exploring the human microbiome and its implications for health and disease is gaining traction, suggesting an increasing interest in the interplay between microbiota and human health.
  6. COVID-19 Related Research:
    Given the global pandemic, there has been a surge in research related to COVID-19, including vaccine development and the understanding of viral mechanisms, which continues to dominate recent publications.

Declining or Waning

Certain themes within Minerva Biotechnology and Biomolecular Research appear to be diminishing in prominence, as indicated by a decline in published works or reduced focus in recent years.
  1. Traditional Pharmacology:
    There seems to be a waning interest in traditional pharmacological studies, potentially due to the shift towards more innovative and targeted therapeutic approaches.
  2. Basic Research Without Clinical Implications:
    There is a noticeable decline in studies that focus solely on basic biological research without clear implications for clinical practice, as the journal increasingly emphasizes translational research.
  3. General Studies on Infectious Diseases:
    While infectious diseases remain a relevant topic, studies that do not provide novel insights into treatment or prevention strategies may be receiving less attention.
  4. Animal Models in Drug Testing:
    Research utilizing animal models for drug testing appears to be less frequent, possibly due to ethical concerns and a growing preference for alternative methods, including in-vitro and in-silico studies.

Similar Journals

BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY

Empowering Research for a Sustainable Future.
Publisher: WILEYISSN: 0885-4513Frequency: 6 issues/year

BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, published by Wiley, is a renowned journal that bridges the gap between fundamental research and practical applications in the fields of biochemistry and biotechnology. With an ISSN of 0885-4513 and an E-ISSN of 1470-8744, this journal has been instrumental since its inception in 1986, focusing on diverse topics including applied microbiology, drug discovery, and process chemistry. The journal is currently recognized in various categories with impressive quartile rankings, showcasing its influence with placements in Q2 for applied microbiology, biotechnology, and biomedical engineering, among others. Researchers and professionals benefit from its comprehensive scope and critical insights into the latest advancements in these domains. Although not an open-access journal, it provides invaluable access options for academic institutions and professionals seeking to stay at the forefront of biotechnology innovations. Its commitment to presenting quality research facilitates the growth of knowledge and fosters collaborations across disciplines, making it an essential resource for anyone invested in the rapidly evolving landscape of biosciences.

FASEB JOURNAL

Pioneering Insights in Biochemistry, Genetics, and Medicine
Publisher: WILEYISSN: 0892-6638Frequency: 12 issues/year

FASEB JOURNAL, published by Wiley, stands as a leading interdisciplinary platform in the realm of biological sciences, prominently featured in the United States. With an impressive 2023 impact factor placing it in the Q1 category across various fields including Biochemistry, Biotechnology, Genetics, Molecular Biology, and Medicine (miscellaneous), the journal is recognized for its substantial contribution to advancing knowledge and innovation. It serves as a vital resource for researchers, professionals, and students alike, providing high-quality, peer-reviewed articles that explore the molecular and cellular mechanisms underlying health and disease. The FASEB JOURNAL not only emphasizes accessible scientific communication but also fosters collaboration within these dynamic fields, making it an essential publication for anyone engaged in cutting-edge life sciences research. To explore more about the journal's offerings and access its vast repository of scholarly articles, visit their official page.

IUBMB LIFE

Connecting Researchers to the Future of Life Sciences
Publisher: WILEYISSN: 1521-6543Frequency: 12 issues/year

IUBMB LIFE is a prestigious, peer-reviewed journal published by WILEY, dedicated to advancing the fields of biochemistry, molecular biology, and cell biology. With an impressive impact factor and consistently ranked in the Q1 and Q2 categories across multiple relevant disciplines—including Biochemistry, Genetics, and Clinical Biochemistry—this journal has established itself as a leading platform for disseminating innovative research and critical reviews that propel scientific discovery. The journal spans a converged publication period from 1999 to 2024, providing comprehensive insights into the dynamic landscape of biochemical research. Researchers, professionals, and students alike are invited to explore its Open Access options, ensuring that groundbreaking studies are accessible to a global audience. As it continues to shape the future of life sciences, IUBMB LIFE remains a vital resource for those seeking to enrich their understanding and contribute to these rapidly evolving fields.

Research Journal of Biotechnology

Exploring the frontiers of biotechnology research.
Publisher: RESEARCH JOURNAL BIOTECHNOLOGYISSN: 2278-4535Frequency: 12 issues/year

Research Journal of Biotechnology is a premier publication dedicated to advancing the field of biotechnology through the dissemination of impactful research articles. Published by Research Journal Biotechnology in India, this journal operates under an Open Access model, facilitating unrestricted access to high-quality research for researchers, professionals, and students worldwide. With an ISSN of 2278-4535 and an E-ISSN of 2278-4535, the journal aims to serve as a comprehensive platform for innovative studies in Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology. Despite its current Q4 quartile ranking in these categories, the journal aspires to extend its influence and visibility in the academic community, aiming for greater impact in the future. The journal features research articles that span a wide array of topics in biotechnology, fostering a collaborative and knowledge-rich environment for national and international scholars. We invite you to explore, contribute to, and engage with the expanding landscape of biotechnological research through the Research Journal of Biotechnology.

Biotechnology Journal

Elevating the impact of biotechnology in modern science.
Publisher: WILEY-V C H VERLAG GMBHISSN: 1860-6768Frequency: 12 issues/year

Biotechnology Journal, published by WILEY-V C H VERLAG GMBH, stands at the forefront of biotechnological research and innovation, recognized for its significant contributions to the fields of applied microbiology, molecular medicine, and broader biotechnology. With its ISSN 1860-6768 and E-ISSN 1860-7314, this journal has achieved impressive 2023 quartile rankings, positioning itself in Q1 for both Applied Microbiology and Biotechnology and Medicine (miscellaneous), and Q2 in Molecular Medicine, showcasing its impact and relevance within the scientific community. Based in Germany, the journal aims to disseminate high-quality research that drives advancements in biotechnological applications, fostering a platform for researchers, professionals, and students to engage with cutting-edge developments. With its ongoing commitment to excellence, the Biotechnology Journal is an essential resource for those seeking to stay informed about the latest trends and innovations in biotechnology.

JOURNAL OF BIOSCIENCES

Championing Impactful Discoveries in Life Sciences
Publisher: INDIAN ACAD SCIENCESISSN: 0250-5991Frequency: 1 issue/year

JOURNAL OF BIOSCIENCES, published by the Indian Academy of Sciences, has established itself as a pioneering platform in the fields of biosciences, encompassing diverse research areas such as agricultural and biological sciences, biochemistry, genetics, molecular biology, and medicine. With an impressive trajectory since its inception in 1979, the journal has achieved notable recognition, securing a Q1 ranking in Agricultural and Biological Sciences and maintaining its place in the top quartiles for Biochemistry and Medicine as of 2023. With Scopus rankings placing it at #32 in General Agricultural and Biological Sciences and #65 in General Biochemistry, Genetics, and Molecular Biology, the journal reaches the 85th and 70th percentiles respectively, reflecting its impact and relevance in current scientific discourse. Although it does not offer open access, the JOURNAL OF BIOSCIENCES remains crucial for researchers, professionals, and students dedicated to advancing knowledge and innovation within the biosciences, providing a vibrant forum for high-quality research and comprehensive reviews.

Biomolecules

Pioneering insights in biochemistry and molecular biology.
Publisher: MDPIISSN: Frequency: 12 issues/year

Biomolecules is a prestigious, peer-reviewed journal published by MDPI that has been dedicated to advancing the field of biochemical research since its launch in 2011. With an impressive impact factor positioning it in Q1 for Biochemistry and Q2 for Molecular Biology as of 2023, this journal serves as a vital platform for disseminating high-quality research findings related to biological macromolecules, including proteins, nucleic acids, and carbohydrates. Operating as an Open Access journal, it ensures that vital research is accessible to all, furthering knowledge dissemination and collaboration within the scientific community. Located in Basel, Switzerland, the journal has established a significant presence in major academic databases, holding commendable Scopus rankings in both Biochemistry and Molecular Biology. Researchers, professionals, and students will find Biomolecules an invaluable resource for cutting-edge research, reviews, and insights in the rapidly evolving domains of biochemistry and molecular biology.

BIOTECHNOLOGY LETTERS

Advancing the Frontiers of Biotechnology Research
Publisher: SPRINGERISSN: 0141-5492Frequency: 12 issues/year

BIOTECHNOLOGY LETTERS is a prestigious peer-reviewed journal that has been at the forefront of biotechnology research since its inception in 1979. Published by Springer, this esteemed journal serves as a vital platform for disseminating cutting-edge research in the fields of applied microbiology, bioengineering, and biotechnology, with a focus on innovative methodologies and technologies. With an impact factor reflecting its critical contribution to the discipline, BIOTECHNOLOGY LETTERS resides in the Q2 and Q3 tiers of various scientific categories, placing it among the notable journals in the biotechnological landscape. Although it offers traditional access options and does not feature open access, the journal embraces a global readership, encouraging submissions from researchers, professionals, and students eager to explore the dynamic advancements in biotechnology. Situated in the Netherlands, it continues to shape the future of the field through relevant, impactful research that addresses contemporary challenges and opportunities in medicine and beyond.

Gene Reports

Advancing Genetic Knowledge for Tomorrow
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Gene Reports is a prominent academic journal published by Elsevier that focuses on the rapidly evolving field of genetics. Launched in 2015, this journal serves as a pivotal platform for the dissemination of cutting-edge research, bridging the gap between basic and applied genetics studies. Although it currently holds a Q4 ranking in the Genetics category and stands at the 248th position out of 347 in Scopus rankings, its potential for growth is significant given the increasing interest in genetic research across various disciplines. With an E-ISSN of 2452-0144, Gene Reports aims to provide open access to original research articles, reviews, and short communications that advance the collective understanding of genetic mechanisms and their applications. As a publication that continues to shape the future of genetics, it is an essential resource for researchers, professionals, and students seeking to stay informed about the latest developments in this crucial field.

ELECTRONIC JOURNAL OF BIOTECHNOLOGY

Empowering Global Collaboration in Biotechnology Research
Publisher: PONTIFICIA UNIV CATOLICA VALPARAISOISSN: 0717-3458Frequency: 6 issues/year

The Electronic Journal of Biotechnology is a premier Open Access journal published by Pontificia Universidad Catolica de Valparaiso, Chile, dedicated to advancing the fields of applied microbiology and biotechnology. With its inception in 1998 and an unwavering commitment to sharing knowledge, the journal has garnered a respectable ranking within the Q3 quartile for both its biotechnology and applied microbiology categories as of 2023, reflecting its significance in the academic community. Researchers and professionals will find its editorial rigor complemented by a robust platform for disseminating innovative findings, fostering collaboration, and driving forward biotechnology discussions. Given its inclusive approach, having transitioned to Open Access in 2014, the journal ensures that research is accessible to a global audience, making it a valuable resource for students, academics, and industry practitioners alike. Through the publication of original research, reviews, and critical insights, the Electronic Journal of Biotechnology aims to bridge the gap between scientific discovery and practical application, ultimately contributing to advancements in health, agriculture, and environmental sustainability.